# Wildcat Capital Management, LLC: Form 13F holdings

An institutional investment manager in NEW YORK, NY. SEC CIK 1582384.

- Quarter ended: 2026-06-30
- Filed: 2026-07-22
- Reported value: $228.5m
- Positions: 3 (3 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1582384/000199937126015582/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [FRONTIER GROUP HLDGS INC (ULCC)](/companies/ulcc.md) | COM | $222.0m | 97.1% | 28,061,351 |  | Unchanged |
| [ALLOGENE THERAPEUTICS INC (ALLO)](/companies/allo.md) | COM | $6.1m | 2.7% | 2,920,787 |  | Unchanged |
| [CHIME FINL INC (CHYM)](/companies/chym.md) | COM SHS CL A | $488.9k | 0.2% | 23,874 |  | New +23,874 |

Source: SEC EDGAR, Form 13F-HR, accession 0001999371-26-015582. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.